<DOC>
	<DOCNO>NCT02298192</DOCNO>
	<brief_summary>This trial conduct Europe , North America United States America . The aim trial compare two different titration algorithm insulin degludec/liraglutide .</brief_summary>
	<brief_title>A Clinical Trial Comparing Efficacy Safety Insulin Degludec/Liraglutide ( IDegLira ) Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes mellitus Male female equal 18 year age HbA1c ( glycosylated haemoglobin ) 7.0 10.0 % [ 53 mmol/mol 86 mmol/mol ] ( inclusive ) , confirmed central laboratory Stable daily treatment metformin ( equal 1500 mg max tolerate dose ) without pioglitazone ( orequal 30 mg ) least 90 day prior screen Body Mass Index ( BMI ) equal 40 kg/m^2 Current use antidiabetic drug ( except metformin pioglitazone ) anticipate change concomitant medication , , opinion investigator , could interfere glucose metabolism ( e.g . systemic corticosteroid ) Previous / current treatment insulin ( short term treatment due intercurrent illness , include gestational diabetes , allow discretion investigator ) Treatment glucagonlike peptide1 ( GLP1 ) receptor agonist , sulpfonylurea , glinides , dipeptidyl peptidase 4 ( DPP4 ) inhibitor sodiumglucose cotransporter 2 ( SGLT2 ) inhibitor within 90 day prior screen visit Impaired liver function , define alanine aminotransferase ( ALAT ) equal 2.5 time upper normal range ( UNR ) Impaired renal function define serumcreatinine equal 133 micromol/L ( equal 1.5 mg/dL ) males equal 125 micromol/L ( equal 1.4 mg/dL ) female , define accord local contraindication metformin Screening calcitonin equal 50 ng/L Proliferative retinopathy maculopathy ( macular oedema ) require acute treatment , accord investigator 's clinical judgment Personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia type 2 ( MEN2 ) History pancreatitis ( acute chronic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>